APEA PRACTICE QUESTIONS
WOMEN'S HEALTH FINAL EXAM AND
PRACTICE EXAM NEWEST 2026 TEST
BANK| WOMEN’S HEALTH APEA
FINAL EXAM PREP WITH COMPLETE
50 REAL EXAM QUESTIONS AND
CORRECT VERIFIED ANSWERS/
ALREADY GRADED A+ (MOST
RECENT!!)
1.m(ModeratemDifficulty)mWhichmofmthemfollowingmgeneticmmutationsmismmostmstronglymassociated
mwithmhereditarymbreastmcancer?
A)mHER2
B)mBRCA1m&mBRCA2
C)mTP53
D)mPTENm-
mCORRECTmANSWERmAnswer:mB)mBRCA1m&mBRCA2Explanation:mMutationsminmBRCA1mandmBRCA2m
increasemthemlifetimemriskmofmbreastmcancermsignificantly.mThesemgenesmfunctionmasmtumormsuppr
essors,mandmtheirmmutationsmleadmtomuncheckedmcellmgrowth.
(HighmDifficulty)mAm50-year-oldmwomanmpresentsmwithmamfirm,mimmobile,mnon-
tendermbreastmmassminmthemuppermoutermquadrant.mTheremismalsompeaumd'orangemskinmdimpling.m
Whatmismthemmostmlikelymunderlyingmcausemofmthemskinmchanges?
A)mInflammatorymresponse
B)mLymphaticmobstruction
C)mIncreasedmvascularmpermeability
D)mHormonalmstimulationm-mCORRECTmANSWERmB)mLymphaticmobstruction
,Explanation:mPeaumd'orangemoccursmduemtomcancerousminvasionmofmdermalmlymphatics,mcausingme
demamandmskinmthickening.
(ModeratemDifficulty)mAmpostmenopausalmwomanmwithmER/PR-
positivembreastmcancermismstartedmonmanastrozole.mWhatmismthemmechanismmofmactionmofmthismdru
g?
A)mSelectivemestrogenmreceptormmodulator
B)mEstrogenmreceptormantagonist
C)mAromataseminhibitor
D)mHER2mreceptorminhibitorm-mCORRECTmANSWERmC)mAromataseminhibitor
Explanation:mAnastrozoleminhibitsmaromatase,mreducingmestrogenmsynthesisminmpostmenopausalm
women,mwhichmismcrucialmformER/PR-positivembreastmcancermtreatment.
(HighmDifficulty)mAmpatientmwithmHER2-
positivembreastmcancermismprescribedmtrastuzumabm(Herceptin).mWhichmofmthemfollowingmadversem
effectsmshouldmbemcloselymmonitored?
A)mNephrotoxicity
B)mCardiotoxicity
C)mHepatotoxicity
D)mPulmonarymfibrosism-mCORRECTmANSWERmB)mCardiotoxicity
Explanation:mTrastuzumabmcanmcausemcardiomyopathy,mleadingmtomreducedmleftmventricularmeject
ionmfractionm(LVEF).mBaselinemandmfollow-upmechocardiogramsmaremrecommended.
AmpremenopausalmwomanmwithmER/PR-
positivembreastmcancermismstartedmonmtamoxifen.mWhatmismthemmostmseriousmpotentialmadversemeff
ect?
A)mOsteoporosis
B)mEndometrialmcancer
C)mHypercalcemia
, D)mPulmonarymembolismm-mCORRECTmANSWERm:mB)mEndometrialmcancer
Explanation:mTamoxifenmismamselectivemestrogenmreceptormmodulatorm(SERM)mthatmactsmasmanmant
agonistminmthembreastmbutmanmagonistminmthemendometrium,mincreasingmthemriskmofmendometrialm
hyperplasiamandmcancer.
Duringmamclinicalmbreastmexam,mam45-year-
oldmpatientmismfoundmtomhavemamnewlymdetected,mfirm,mnon-
tendermbreastmmassmwithmirregularmbordersminmthemuppermoutermquadrant.mWhatmismthemnextmbes
tmstepminmevaluatingmthismmass?
A)mOrdermamdiagnosticmmammogrammandmultrasound
B)mSchedulemamfollow-upmexamminm6mmonths
C)mStartmempiricalmantibioticmtherapy
D)mReassuremthempatientmandmadvisemself-monitoringm-
mCORRECTmANSWERmA)mOrdermamdiagnosticmmammogrammandmultrasoundExplanation:mAnymnew,
mpersistentmbreastmmassminmamwomanm>40myearsmoldmshouldmbemevaluatedmwithmdiagnosticmimagi
ngm(mammogramm±multrasound).mIfmfindingsmaremsuspicious,mambiopsymismneededmformdefinitivemdi
agnosis.
WhichmofmthemfollowingmbestmdescribesmthemrolemofmHER2m(humanmepidermalmgrowthmfactormrec
eptorm2)minmbreastmcancermpathophysiology?
A)mItmfunctionsmasmamtumormsuppressormgene,mandmitsmmutationmleadsmtomuncheckedmcellmgrowth
B)mItmenhancesmtumormproliferationmandmismassociatedmwithmaggressivembreastmcancermsubtypes
C)mItmincreasesmestrogenmproduction,mpromotingmhormonemreceptor-positivemcancer
D)mItmregulatesmapoptosis,mandmitsmoverexpressionmcausesmincreasedmcellmdeathm-
mCORRECTmANSWERmAnswer:mB)mItmenhancesmtumormproliferationmandmismassociatedmwithmaggres
sivembreastmcancermsubtypes
Explanation:mHER2mismamproto-
oncogenemthatmpromotesmcellmgrowthmandmdivision.mOverexpressionmofmHER2minmbreastmcancermis
mlinkedmtomaggressivemtumors,mpoormprognosis,mandmincreasedmrecurrencemrisk,mbutmtrastuzumab
m(Herceptin)mcanmspecificallymtargetmHER2-positivemcancermcells.
WOMEN'S HEALTH FINAL EXAM AND
PRACTICE EXAM NEWEST 2026 TEST
BANK| WOMEN’S HEALTH APEA
FINAL EXAM PREP WITH COMPLETE
50 REAL EXAM QUESTIONS AND
CORRECT VERIFIED ANSWERS/
ALREADY GRADED A+ (MOST
RECENT!!)
1.m(ModeratemDifficulty)mWhichmofmthemfollowingmgeneticmmutationsmismmostmstronglymassociated
mwithmhereditarymbreastmcancer?
A)mHER2
B)mBRCA1m&mBRCA2
C)mTP53
D)mPTENm-
mCORRECTmANSWERmAnswer:mB)mBRCA1m&mBRCA2Explanation:mMutationsminmBRCA1mandmBRCA2m
increasemthemlifetimemriskmofmbreastmcancermsignificantly.mThesemgenesmfunctionmasmtumormsuppr
essors,mandmtheirmmutationsmleadmtomuncheckedmcellmgrowth.
(HighmDifficulty)mAm50-year-oldmwomanmpresentsmwithmamfirm,mimmobile,mnon-
tendermbreastmmassminmthemuppermoutermquadrant.mTheremismalsompeaumd'orangemskinmdimpling.m
Whatmismthemmostmlikelymunderlyingmcausemofmthemskinmchanges?
A)mInflammatorymresponse
B)mLymphaticmobstruction
C)mIncreasedmvascularmpermeability
D)mHormonalmstimulationm-mCORRECTmANSWERmB)mLymphaticmobstruction
,Explanation:mPeaumd'orangemoccursmduemtomcancerousminvasionmofmdermalmlymphatics,mcausingme
demamandmskinmthickening.
(ModeratemDifficulty)mAmpostmenopausalmwomanmwithmER/PR-
positivembreastmcancermismstartedmonmanastrozole.mWhatmismthemmechanismmofmactionmofmthismdru
g?
A)mSelectivemestrogenmreceptormmodulator
B)mEstrogenmreceptormantagonist
C)mAromataseminhibitor
D)mHER2mreceptorminhibitorm-mCORRECTmANSWERmC)mAromataseminhibitor
Explanation:mAnastrozoleminhibitsmaromatase,mreducingmestrogenmsynthesisminmpostmenopausalm
women,mwhichmismcrucialmformER/PR-positivembreastmcancermtreatment.
(HighmDifficulty)mAmpatientmwithmHER2-
positivembreastmcancermismprescribedmtrastuzumabm(Herceptin).mWhichmofmthemfollowingmadversem
effectsmshouldmbemcloselymmonitored?
A)mNephrotoxicity
B)mCardiotoxicity
C)mHepatotoxicity
D)mPulmonarymfibrosism-mCORRECTmANSWERmB)mCardiotoxicity
Explanation:mTrastuzumabmcanmcausemcardiomyopathy,mleadingmtomreducedmleftmventricularmeject
ionmfractionm(LVEF).mBaselinemandmfollow-upmechocardiogramsmaremrecommended.
AmpremenopausalmwomanmwithmER/PR-
positivembreastmcancermismstartedmonmtamoxifen.mWhatmismthemmostmseriousmpotentialmadversemeff
ect?
A)mOsteoporosis
B)mEndometrialmcancer
C)mHypercalcemia
, D)mPulmonarymembolismm-mCORRECTmANSWERm:mB)mEndometrialmcancer
Explanation:mTamoxifenmismamselectivemestrogenmreceptormmodulatorm(SERM)mthatmactsmasmanmant
agonistminmthembreastmbutmanmagonistminmthemendometrium,mincreasingmthemriskmofmendometrialm
hyperplasiamandmcancer.
Duringmamclinicalmbreastmexam,mam45-year-
oldmpatientmismfoundmtomhavemamnewlymdetected,mfirm,mnon-
tendermbreastmmassmwithmirregularmbordersminmthemuppermoutermquadrant.mWhatmismthemnextmbes
tmstepminmevaluatingmthismmass?
A)mOrdermamdiagnosticmmammogrammandmultrasound
B)mSchedulemamfollow-upmexamminm6mmonths
C)mStartmempiricalmantibioticmtherapy
D)mReassuremthempatientmandmadvisemself-monitoringm-
mCORRECTmANSWERmA)mOrdermamdiagnosticmmammogrammandmultrasoundExplanation:mAnymnew,
mpersistentmbreastmmassminmamwomanm>40myearsmoldmshouldmbemevaluatedmwithmdiagnosticmimagi
ngm(mammogramm±multrasound).mIfmfindingsmaremsuspicious,mambiopsymismneededmformdefinitivemdi
agnosis.
WhichmofmthemfollowingmbestmdescribesmthemrolemofmHER2m(humanmepidermalmgrowthmfactormrec
eptorm2)minmbreastmcancermpathophysiology?
A)mItmfunctionsmasmamtumormsuppressormgene,mandmitsmmutationmleadsmtomuncheckedmcellmgrowth
B)mItmenhancesmtumormproliferationmandmismassociatedmwithmaggressivembreastmcancermsubtypes
C)mItmincreasesmestrogenmproduction,mpromotingmhormonemreceptor-positivemcancer
D)mItmregulatesmapoptosis,mandmitsmoverexpressionmcausesmincreasedmcellmdeathm-
mCORRECTmANSWERmAnswer:mB)mItmenhancesmtumormproliferationmandmismassociatedmwithmaggres
sivembreastmcancermsubtypes
Explanation:mHER2mismamproto-
oncogenemthatmpromotesmcellmgrowthmandmdivision.mOverexpressionmofmHER2minmbreastmcancermis
mlinkedmtomaggressivemtumors,mpoormprognosis,mandmincreasedmrecurrencemrisk,mbutmtrastuzumab
m(Herceptin)mcanmspecificallymtargetmHER2-positivemcancermcells.
